1. 3-Methyladenine can depress drug efflux transporters via blocking the PI3K–AKT–mTOR pathway thus sensitizing MDR cancer to chemotherapy. (November 2014) Authors: Zou, Zhenyou; Zhang, Jing; Zhang, Haiyang; Liu, Huan; Li, Zhiguo; Cheng, Dan; Chen, Jun; Liu, Lu; Ni, Mengjie; Zhang, Yu; Yao, Jun; Zhou, Jun; Fu, Junjie; Liang, Yong Journal: Journal of drug targeting Issue: Volume 22:Number 9(2014) Page Start: 839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial status. (7th February 2022) Authors: Kumar Gupta, Dipak; Ali, Mohd Humair; Ali, Asad; Jain, Pooja; Anwer, Md. Khalid; Iqbal, Zeenat; Mirza, Mohd. Aamir Journal: Journal of drug targeting Issue: Volume 30:Number 2(2022) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A bispecific decoy receptor VEGFR-EGFR/Fc binding EGF-like ligands and VEGF shows potent antitumor efficacy. (16th March 2022) Authors: Guo, Xiao-Fang; Zhang, Yue-Yue; Kang, Jia; Dou, Qiao-Hua; Zhu, Xiao-Fei Journal: Journal of drug targeting Issue: Volume 30:Number 3(2022) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A celebration of Professor Leaf Huang's contribution to the field of drug delivery and his lifetime achievement award. (28th May 2018) Authors: Li, Shyh-Dar Journal: Journal of drug targeting Issue: Volume 26:Number 5/6(2018) Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A celebration of the contributions of professor Pieter Cullis to the fields of membrane biophysics, nanotechnology and nanomedicine. (20th October 2016) Authors: Allen, Theresa M. Journal: Journal of drug targeting Issue: Volume 24:Number 9(2016) Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A comprehensive review on the antiviral activities of chalcones. (21st April 2021) Authors: Elkhalifa, Dana; Al-Hashimi, Israa; Al Moustafa, Ala-Eddin; Khalil, Ashraf Journal: Journal of drug targeting Issue: Volume 29:Number 4(2021) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A dual-functional buformin-mimicking poly(amido amine) for efficient and safe gene delivery. (20th October 2020) Authors: Lu, Mei; Xing, Haonan; Cheng, Lin; Liu, Hui; Lang, Lang; Yang, Tianzhi; Zhao, Xiaoyun; Xu, Hui; Ding, Pingtian Journal: Journal of drug targeting Issue: Volume 28:Number 9(2020) Page Start: 923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles. (3rd July 2019) Authors: Vauthier, Christine Journal: Journal of drug targeting Issue: Volume 27:Number 5/6(2019) Page Start: 502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis. (May 2015) Authors: Chen, Yi; Peng, Jianqing; Han, Miaomiao; Omar, Mezghrani; Hu, Danrong; Ke, Xue; Lu, Na Journal: Journal of drug targeting Issue: Volume 23:Number 4(2015) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A mechanistic insight into benefits of aggregation induced emissive luminogens in cancer. (3rd July 2021) Authors: Kumari, Rashmi; Sunil, Dhanya Journal: Journal of drug targeting Issue: Volume 29:Number 6(2021) Page Start: 592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗